MARKET

LFVN

LFVN

Lifevantage Corp
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.770
0.000
0.00%
Closed 16:00 06/24 EDT
OPEN
4.790
PREV CLOSE
4.770
HIGH
4.840
LOW
4.770
VOLUME
41.87K
TURNOVER
168.46K
52 WEEK HIGH
8.63
52 WEEK LOW
3.775
MARKET CAP
60.05M
P/E (TTM)
6.88
1D
5D
1M
3M
1Y
5Y
LifeVantage Hosts Activate 2022, Introduces Activating TrueScience® Liquid Collagen to U.S. Market
Rare Key Ingredient Red Quinoa Activates Natural Collagen Synthesis and Increases Collagen Density by 42%SALT LAKE CITY, June 21, 2022 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a pioneer in nutrigenomics, hosted Activate 2022 throughout t...
GlobeNewswire · 5d ago
Some Investors May Be Worried About LifeVantage's (NASDAQ:LFVN) Returns On Capital
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Amongst other things, we'll want to...
Simply Wall St. · 5d ago
What Does LifeVantage Corporation's (NASDAQ:LFVN) Share Price Indicate?
While LifeVantage Corporation ( NASDAQ:LFVN ) might not be the most widely known stock at the moment, it received a lot...
Simply Wall St. · 05/16 12:25
5 Value Stocks In The Consumer Defensive Sector
The Meaning Behind Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most ...
Benzinga · 05/06 14:40
LifeVantage declares $0.03 dividend
LifeVantage (NASDAQ:LFVN) declares $0.03/share quarterly dividend. Forward yield 2.87% Payable May 31; for shareholders of record May 17; ex-div May 16. See LFVN Dividend Scorecard, Yield Chart, & Dividend Growth.
Seekingalpha · 05/03 20:51
BRIEF-Lifevantage Q3 Adj EPS $0.12
reuters.com · 05/03 20:44
LifeVantage Non-GAAP EPS of $0.12, revenue of $50M
LifeVantage press release (NASDAQ:LFVN): Q3 Non-GAAP EPS of $0.12. Revenue of $50M (-6.0% Y/Y). Revenue for fiscal 2022 is now expected to be in the range of $204 million to
Seekingalpha · 05/03 20:29
Lifevantage Q3 EPS $0.12 Beats $0.11 Estimate, Sales $50.00M Miss $50.10M Estimate
Lifevantage (NASDAQ:LFVN) reported quarterly earnings of $0.12 per share which beat the analyst consensus estimate of $0.11 by 9.09 percent. This is a 40 percent decrease over earnings of $0.20 per share from the same
Benzinga · 05/03 20:22
More
No Data
Learn about the latest financial forecast of LFVN. Analyze the recent business situations of Lifevantage Corp through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

0.00%Strong Buy
100.00%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average LFVN stock price target is 7.00 with a high estimate of 7.00 and a low estimate of 7.00.
High7.00
Average7.00
Low7.00
Current 4.770
EPS
Actual
Estimate
0.080.160.230.31
Q4 2021
Q1 2022
Q2 2022
Q3 2022
Q4 2022
Institutional Holdings
Institutions: 88
Institutional Holdings: 3.97M
% Owned: 31.52%
Shares Outstanding: 12.59M
TypeInstitutionsShares
Increased
11
69.72K
New
3
49.49K
Decreased
19
259.38K
Sold Out
7
58.66K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
+2.68%
Pharmaceuticals & Medical Research
+2.48%
Key Executives
Non-Executive Chairman/Independent Director
Garry Mauro
President/Chief Executive Officer/Director
Steven Fife
Chief Financial Officer
Carl Aure
Chief Operating Officer
Matthew Cooley
General Counsel/Secretary
Alissa Neufeld
Director
Cynthia Latham
Independent Director
Michael Beindorff
Independent Director
Erin Brockovich
Independent Director
Raymond Greer
Independent Director
Darwin Lewis
No Data
No Data
About LFVN
LifeVantage Corporation is engaged in the business of identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath & body, and targeted relief products. Its products include Protandim, LifeVantage Omega+, ProBio and Daily Wellness dietary supplements, TrueScience, Axio and PhysIQ. LifeVantage Omega+ is a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and Vitamin D3 to support cognitive health, cardiovascular health, skin health, and the immune system. ProBio is a dietary supplement designed to support optimal digestion and immune system function. Daily Wellness is a dietary supplement designed to support and strengthen immune health. TrueScience, which consists of facial cleanser, perfecting lotion, eye serum. PhysIQ, which consists of fat burn, prebiotic and whey protein.

Webull offers kinds of LifeVantage Corp stock information, including NASDAQ:LFVN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LFVN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading LFVN stock methods without spending real money on the virtual paper trading platform.